Showing results (161-170 of 305) with videos related to

Sort By:
Pageof 31
American Journal of Speech-Language Pathology|November 18, 2025
Preliminary Psychometric Review of Neurologists' Speech Ratings on the Unified Parkinson's Disease Rating ScaleKimberly L Dahl, Magdalen A Balz, Kara M Smith, et al.
Cancer Practice|May 25, 2002
Success of the state pain initiatives: moving pain management forwardJune L Dahl, Mary E Bennett, Matthew D Bromley, et al.
Clinical Pharmacology and Therapeutics|July 1, 1989
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beingsM L Dahl-Puustinen, A Lidén, C Alm, et al.
Pharmacogenetics|January 14, 2000
Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genesP Dalén, M L Dahl, M Eichelbaum, et al.
Pharmacology & Toxicology|May 1, 1996
Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian populationT Marandi, M L Dahl, R A Kiivet, et al.
Journal of Bacteriology|April 1, 1995
Transcription activation at the Escherichia coli uhpT promoter by the catabolite gene activator proteinT J Merkel, J L Dahl, R H Ebright, et al.
Journal of Voice : Official Journal of the Voice Foundation|September 21, 2024
The Effects of Speaker Head Posture on Auditory Perception of Vocal MasculinityClaire E Howerton, Daniel P Buckley, Kimberly L Dahl, et al.
Pain Medicine (Malden, Mass.)|December 17, 2009
Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practicesMarla Z Wolfert, Aaron M Gilson, June L Dahl, et al.
Journal of Voice : Official Journal of the Voice Foundation|March 14, 2020
Listener Age and Gender Diversity: Effects on Voice-based Perception of GenderKatherine M Brown, Kimberly L Dahl, Gabriel J Cler, et al.
Pageof 31